GSK Ups Legal Reserve, May Break Pfizer's Settlement Record
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithkline expects to record a $3.4 billion legal charge relating to a government investigation of its marketing practices and Avandia product liability suits.